RU1662 "reverses the effects of a chemical messenger in the brain called GABA – a neurotransmitter that inhibits brain activity. The drug acts on a specific type of brain receptor found mostly in the hippocampus, a part of the brain involved in memory. It is thought that it will reduce excessive inhibition in the hippocampus, thought to underlie memory and learning problems commonly seen in people with Down's."
The drug is currently in trials with 33 adults with Down's assessing its safety.
No comments:
Post a Comment